Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 141 pseudogene (ENSG00000258091) is a genomic sequence annotated as a pseudogene. Pseudogenes are DNA regions that resemble functional genes but contain mutations or disruptions (such as stop codons or frameshifts) that prevent them from producing functional proteins[1][3][4][5]. While some pseudogenes can exert regulatory effects (for example, through RNA molecules that affect the expression of other genes), there is no evidence that TMEM141P is biologically active or clinically relevant in this capacity[3][4][7]. It has no documented role as a receptor, enzyme, transporter, or established therapeutic target. It may share sequence similarity with the transmembrane protein 141 gene (TMEM141), but unlike TMEM141, it does not encode a transmembrane protein and has no known molecular function or link to disease.
None. Drugs do not act on this pseudogene, so no mechanism of action is defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 141 pseudogene (TMEM141P).